Cobra Biomanufacturing (AIM: CBF), the international manufacturer of biopharmaceuticals, today announces the appointment of Andrew Arrage as Vice President, Business Development for the Eastern US region. The opening of an East Coast sales office supports Cobra’s continued expansion of its North American contract manufacturing business.
